SCHEMBL21139365

SCHEMBL21139365

CC(NC(=O)/C=C/c1ccc(O)cc1)C(=O)Oc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ TAS2R31 P59538 2/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ ADORA3 P0DMS8 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ ATM Q13315 1/20 0.56
▸ CYP3A4 P08684 2/20 0.53
▸ CYP1A1 P04798 2/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ CYP1B1 Q16678 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ CA12 O43570 1/20 0.53
▸ SLCO2B1 O94956 1/20 0.53
▸ TTR P02766 1/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ SHBG P04278 1/20 0.53
▸ CALM1 P0DP23 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21139388 0.82 CYP19A1 (0.56) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
SCHEMBL21140118 0.79 CYP19A1 (0.52) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
SCHEMBL21139391 0.78 CYP19A1 (0.55) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
SCHEMBL21140296 0.74 ESR1 (0.44) CYP19A1TDP1TAS2R31MAPTCYP3A4
Sakuranetin SCHEMBL29928748 0.74 CYP19A1 (1.00) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
Sakuranetin SCHEMBL555542 0.74 CYP19A1 (1.00) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
Sakuranetin SCHEMBL555541 0.74 CYP19A1 (1.00) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
Sakuranetin SCHEMBL14410473 0.74 CYP19A1 (1.00) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
SCHEMBL14355413 0.73 BCHE (0.72) CYP19A1TDP1TAS2R31ALDH1A1ADORA3
SCHEMBL22571076 0.73 BCHE (0.72) CYP19A1TDP1TAS2R31ALDH1A1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111265-A1 COMPOUNDS AND METHODS FOR TREATING CANCER SHARE GAL RESEARCH AND DEVELOPMENT LTD (IL) 2019-06-13 — — WO disclosed
Send feedback